1-2 of 2
Yorick Sandberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frail subgroups determine heterogeneous outcomes in older patients with NDMM - long-term follow-up of the HOVON 143 trial

Open Access
Clinical Trials & Observations
Febe Smits, Kaz Groen, Mark-David Levin, Claudia A.M. Stege, Roel J.W. van Kampen, Ellen van der Spek, Inger S. Nijhof, Yavuz M. Bilgin, Noortje Thielen, Inge Ludwig, Esther G.M. de Waal, Yorick Sandberg, Alain Kentos, Gert-Jan Timmers, Josien C. Regelink, Matthijs Westerman, Koen de Heer, Marie-Christiane MB Vekemans, Nazik Durdu-Rayman, Nicole C.H.P. de Graauw, Maarten R. Seefat, Niels W.C.J. van de Donk, Paula F Ypma, Kazem Nasserinejad, Sonja Zweegman
Journal: Blood Advances
Blood Adv bloodadvances.2025017394.
https://doi.org/10.1182/bloodadvances.2025017394
Published: 2025
Includes: Supplemental data
Journal Articles

Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP

Open Access
Clinical Trials & Observations
Marcel Nijland, Djamila E. Issa, Johanna A. A. Bult, Dries Deeren, Gerjo A. Velders, Marten R. Nijziel, Yorick Sandberg, Vibeke Vergote, Margriet Oosterveld, Rob Fijnheer, Rolf E. Brouwer, Rinske S. Boersma, Kalung Wu, Laurens Nieuwenhuizen, Joost S. P. Vermaat, Roel J. W. van Kampen, Wim E. Terpstra, Sylvia Snauwaert, Marjolein W. van der Poel, Eva de Jongh, Marc F. Durian, Leonie Strobbe, Aart Beeker, Alain Gadisseur, Roos S. van Rijn, Otto Visser, Jeanette K. Doorduijn, Tjeerd J. F. Snijders, Matthijs H. Silbermann, Daphne de Jong, Martine Chamuleau, Rogier Mous, Hilde Jalving, Heleen Visser-Wisselaar, Sonja Jansen van de Bergh, Gerben J. C. Zwezerijnen, Edwin Bremer, Mirian Brink, Arjan Diepstra, Dana A. Chitu, Harry R. Koene, Josée M. Zijlstra
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3530–3539.
https://doi.org/10.1182/bloodadvances.2024015226
Published: 2025
Includes: Supplemental data